RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BELLò M
Collezione AOU Città della Salute di Torino

Items : 9

Event-free survival after (68) Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2022 Jul;49(9):3257-3268. doi: 10.1007/s00259-022-05741-9. Epub 2022 Feb

2022
AOU Città della Salute di Torino

Ricardi U; Gontero P; Bellò M; Grimaldi S; Liberini V; Dall'Armellina S; Oderda M; Passera R; Chiofalo V; Guarneri A; Iorio GC; Rovera G; Ceci F; Deandreis D;

Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma. in Frontiers in oncology / Front Oncol. 2022 Aug 29;12:920073. doi: 10.3389/fonc.2022.920073. eCollection 2022.

2022
AOU Città della Salute di Torino

Lagattuta F; Masi G; Ialuna S; Grimaldi S; Fonio P; Finessi M; Doriguzzi A; De Simone P; Deandreis D; Deagostini S; D'Amico M; D'Amato F; Crocetti L; Cioni R; Carucci P; Brunetto M; Bellò M; Bavetta MG; Bargellini I; Barcellona MR; Rognoni C; Moreci A; Scalisi D; Virdone R; Tarricone R;

(68)Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2804-2815. doi: 10.1007/s00259-020-04809-8. Epub 2020 Ap

2020
AOU Città della Salute di Torino

Parise R; Carlevato R; Bellò M; Zitella A; Passera R; Pilati E; Nicolotti DG; Oderda M; Bartoncini S; Lillaz B; Ceci F; Guarneri A; Deandreis D; Ricardi U; Gontero P;

Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience. in Annals of hematology / Ann Hematol. 2018 Sep;97(9):1619-1626. doi: 10.1007/s00277-018-3328-3. Epub 2018 Apr 16.

2018
AOU Città della Salute di Torino

Bisi G; Pregno P; Pecoraro C; Orsucci L; Nicolosi M; Freilone R; Chiappella A; Castellino A; Boccomini C; Benevolo G; Bellò M; Passera R; Botto B; Ciochetto C; Vitolo U; Ciochetto C; Botto B; Passera R; Bellò M; Benevolo G; Boccomini C; Castellino A; Chiappella A; Freilone R; Nicolosi M; Orsucci L; Pecoraro C; Pregno P; Bisi G; et alii...

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe). in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21

2018
AO Cuneo
AOU Città della Salute di Torino

Fanti S; Ghedini P; Cavo M; Gamberi B; Gay F; Patriarca F; Gallamini A; Bellò M; Bertone E; Rensi M; Bianchi A; Chauvie S; Nanni C; Versari A; Zamagni E;

Interventional locoregional treatment and metabolic response: advantages of using PET/CT in the evaluation of response to treatment. in The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... / Q J Nucl Med Mol Imaging. 2018 Jun;62(2):165-184. doi: 10.23736/S1824-4785.17.03037-0. Epub 2017 Nov

2018
AOU Città della Salute di Torino

Veltri A; Giunta FP; Bellò M; Finessi M; Deandreis D;

Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe). in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):414-21. doi: 10.1007/s00259-015-3200-9. Epub 2015 Oct 16.

2016
AO Cuneo
AOU Città della Salute di Torino

Fanti S; Gamberi B; Cavo M; Gay F; Patriarca F; Gallamini A; Rambaldi I; Rensi M; Bellò M; Bianchi A; Versari A; Chauvie S; Zamagni E; Nanni C;

Prognostic Role of Pre-Radiation Therapy (18)F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus Radiation. in International journal of radiation oncology, biology, physics / Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1239-43. doi: 10.1016/j.ijrobp.2016.02.057. Epub 201

2016
AOU Città della Salute di Torino

Filippi AR; Piva C; Levis M; Chiappella A; Caracciolo D; Bellò M; Bisi G; Vitolo U; Ricardi U; Filippi AR; Piva C; Levis M; Chiappella A; Caracciolo D; Bellò M; Bisi G; Vitolo U; Ricardi U;

Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use? in The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... / Q J Nucl Med Mol Imaging. 2015 Jun;59(2):214-9. Epub 2015 Feb 11.

2015
AOU Città della Salute di Torino

Giunta F; Zotta M; Menga M; Balma M; Bellò M; Passera R; Filippi AR; Chiappella A; Ladetto M; Ricardi U; Vitolo U; Bisi G;